The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antiviral Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
The global Antiviral Drugs market size is expected to reach US$ 51390 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antiviral Drugs in various end use industries. The expanding demands from the Hepatitis Therapeutics, HIV/AIDS Therapeutics, Herpes Therapeutics and Influenza Therapeutics, are propelling Antiviral Drugs market. Reverse Transcriptase Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Protease Inhibitors segment is estimated at % CAGR for the next seven-year period.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antiviral Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antiviral Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antiviral Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antiviral Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antiviral Drugs covered in this report include Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and AbbVie, etc.
The global Antiviral Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie
Global Antiviral Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antiviral Drugs market, Segment by Type:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Global Antiviral Drugs market, by Application
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antiviral Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antiviral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
The global Antiviral Drugs market size is expected to reach US$ 51390 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antiviral Drugs in various end use industries. The expanding demands from the Hepatitis Therapeutics, HIV/AIDS Therapeutics, Herpes Therapeutics and Influenza Therapeutics, are propelling Antiviral Drugs market. Reverse Transcriptase Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Protease Inhibitors segment is estimated at % CAGR for the next seven-year period.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antiviral Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antiviral Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antiviral Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antiviral Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antiviral Drugs covered in this report include Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and AbbVie, etc.
The global Antiviral Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie
Global Antiviral Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antiviral Drugs market, Segment by Type:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Global Antiviral Drugs market, by Application
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antiviral Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antiviral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antiviral Drugs Market Overview
1.1 Antiviral Drugs Product Overview
1.2 Antiviral Drugs Market Segment by Type
1.2.1 Reverse Transcriptase Inhibitors
1.2.2 Protease Inhibitors
1.2.3 Fusion Inhibitors
1.2.4 Immune System Modulators
1.3 Global Antiviral Drugs Market Size by Type
1.3.1 Global Antiviral Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antiviral Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antiviral Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antiviral Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antiviral Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antiviral Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antiviral Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antiviral Drugs Sales Breakdown by Type (2018-2023)
2 Global Antiviral Drugs Market Competition by Company
2.1 Global Top Players by Antiviral Drugs Sales (2018-2023)
2.2 Global Top Players by Antiviral Drugs Revenue (2018-2023)
2.3 Global Top Players by Antiviral Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antiviral Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antiviral Drugs Market Competitive Situation and Trends
2.5.1 Antiviral Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antiviral Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiviral Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antiviral Drugs Market
2.8 Key Manufacturers Antiviral Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antiviral Drugs Status and Outlook by Region
3.1 Global Antiviral Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antiviral Drugs Historic Market Size by Region
3.2.1 Global Antiviral Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antiviral Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antiviral Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antiviral Drugs Forecasted Market Size by Region
3.3.1 Global Antiviral Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antiviral Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antiviral Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antiviral Drugs by Application
4.1 Antiviral Drugs Market Segment by Application
4.1.1 Hepatitis Therapeutics
4.1.2 HIV/AIDS Therapeutics
4.1.3 Herpes Therapeutics
4.1.4 Influenza Therapeutics
4.2 Global Antiviral Drugs Market Size by Application
4.2.1 Global Antiviral Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Antiviral Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antiviral Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antiviral Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antiviral Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antiviral Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antiviral Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antiviral Drugs Sales Breakdown by Application (2018-2023)
5 North America Antiviral Drugs by Country
5.1 North America Antiviral Drugs Historic Market Size by Country
5.1.1 North America Antiviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antiviral Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antiviral Drugs Sales in Value by Country (2018-2023)
5.2 North America Antiviral Drugs Forecasted Market Size by Country
5.2.1 North America Antiviral Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antiviral Drugs Sales in Value by Country (2024-2029)
6 Europe Antiviral Drugs by Country
6.1 Europe Antiviral Drugs Historic Market Size by Country
6.1.1 Europe Antiviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antiviral Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antiviral Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antiviral Drugs Forecasted Market Size by Country
6.2.1 Europe Antiviral Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antiviral Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antiviral Drugs by Region
7.1 Asia-Pacific Antiviral Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antiviral Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antiviral Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antiviral Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antiviral Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antiviral Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antiviral Drugs Sales in Value by Region (2024-2029)
8 Latin America Antiviral Drugs by Country
8.1 Latin America Antiviral Drugs Historic Market Size by Country
8.1.1 Latin America Antiviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antiviral Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antiviral Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antiviral Drugs Forecasted Market Size by Country
8.2.1 Latin America Antiviral Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antiviral Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antiviral Drugs by Country
9.1 Middle East and Africa Antiviral Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antiviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antiviral Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antiviral Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antiviral Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antiviral Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antiviral Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Antiviral Drugs Products Offered
10.1.5 Roche Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Antiviral Drugs Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Antiviral Drugs Products Offered
10.3.5 Merck Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Antiviral Drugs Products Offered
10.4.5 Novartis Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Information
10.5.2 Bristol-Myers Squibb Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bristol-Myers Squibb Antiviral Drugs Products Offered
10.5.5 Bristol-Myers Squibb Recent Development
10.6 Gilead Sciences
10.6.1 Gilead Sciences Company Information
10.6.2 Gilead Sciences Introduction and Business Overview
10.6.3 Gilead Sciences Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Gilead Sciences Antiviral Drugs Products Offered
10.6.5 Gilead Sciences Recent Development
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Information
10.7.2 GlaxoSmithKline Introduction and Business Overview
10.7.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GlaxoSmithKline Antiviral Drugs Products Offered
10.7.5 GlaxoSmithKline Recent Development
10.8 AbbVie
10.8.1 AbbVie Company Information
10.8.2 AbbVie Introduction and Business Overview
10.8.3 AbbVie Antiviral Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AbbVie Antiviral Drugs Products Offered
10.8.5 AbbVie Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antiviral Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antiviral Drugs Industrial Chain Analysis
11.4 Antiviral Drugs Market Dynamics
11.4.1 Antiviral Drugs Industry Trends
11.4.2 Antiviral Drugs Market Drivers
11.4.3 Antiviral Drugs Market Challenges
11.4.4 Antiviral Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antiviral Drugs Distributors
12.3 Antiviral Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
